Fundraising Fox

Tempothera

Delaware corporation · 1 known investors

tempothera.com ↗

Tempo Thera develops tissue engineering products using MAP technology that combine immunomodulation and material science for soft tissue reconstruction in surgical settings. The company builds functional tissue and organs to treat patients with dermal and abdominal wall indications, with expanding pipeline into drug delivery, cell engraftment, and vaccine technologies.

BiotechHealthtechMedical Devicesin /tempo-therapeutics

Founders & leadership

WW
Westbrook WeaverExecutive Officer, Director, Promoter
SR
Steven RichieriExecutive Officer, Director
RH
Richard HancockDirector
DD
Dino Di CarloDirector
DG
Donald GriffinDirector

Investors · 1

Sugati VenturesSan Ramon

Reported raises · per SEC filings

Form D private placements
▶$16.3MraisedMar 2024 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard HancockDirector
  • Donald GriffinDirector
  • Steven RichieriDirector
  • Robin SitverDirector
  • Steven SandsDirector
  • Biren MehtaDirector
  • Westbrook WeaverExecutive Officer, Director
Offering amount
$16.8M
Amount sold
$16.3M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedAug 2021 · 39 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Westbrook WeaverExecutive Officer, Director, Promoter
  • Steven RichieriExecutive Officer, Director
  • Richard HancockDirector
  • Dino Di CarloDirector
  • Donald GriffinDirector
Offering amount
$3.9M
Amount sold
$3.8M
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.